At a medical conference I asked a Chairman of Medicine of a prestigious university how he would treat a man who had a massive heart attack with a cholesterol of only 140, LDL of 50 and no other risk factors. He said ‘That’s a no brainer – give him a high dose statin.’ I then said, “That man’s cholesterol and LDL are excellent. It’s probably only inflammation or a clot, so one could use vitamins and other nutrients instead.” He abruptly and arrogantly said ‘No, give him a statin’ and he turned away.
Dr Pauling found that Lipoprotein(a) increases when vitamin C levels are low, perhaps as a protective mechanism since Lipoprotein(a) binds to weakened arterial walls (less collagen and elastin fibers) to repair damage – like a patch. Dr. Pauling thought cardiovascular disease is a form of chronic pre-scurvy. Read what he recommends.
Amgen, the maker of evolocumab (Repatha) funded the research, paid EVERY author on the paper, led by Harvard researchers, and the findings were published in the prestigious New England Journal of Medicine May 4, 2017. If you take the drug, evolocumab (Repatha), your LDL will go down but you won’t live any longer. IT’S ALL ABOUT INFLAMMATION AND OXIDATION.
Inflammation plays an important role in an acute soft tissue injury. Overall, R.I.C.E. generally delays repair and recovery.
Ribose looks and tastes like sugar and has a negative glycemic index which causes a drop in blood sugar rather than a rise.
Foods that increase blood sugar will also increase small LDL particles within two hours. Small LDL particles are oxidized and are glycalated – form complexes with glucose that lead to inflammation and oxidation increasing the risk for cardiovascular disease, cancer, and other chronic illnesses.
INFLAMMATION AND OXIDATION DECREASE ATHLETIC PERFORMANCE AND INCREASE THE RISK FOR CANCER, CARDIOVASCULAR DISEASE, DIABETES, DEMENTIA, AND MANY OTHER CHRONIC DISEASES AS WELL AS SHORTENED LIFESPANS